Negocie MerckCo USA MRK

Gráfico MerckCo ao vivo

Fundamentos do instrumento

Weekly Search
Weekly
Daily
Data Fechar Mudança Alteração (%): Abertura Max Min

MerckCo news

Big Tech, Apple, Meta, Microsoft, Amazon & Alphabet
Neil Wilson 2024 Oct 24, 16:00

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Forex Indices
Bank of England, BoJ, Fed all hold policy meetings this week
Georgy Istigechev 2024 Jul 25, 16:00

Week ahead: Eurozone inflation, Fed meeting, Apple earnings

Forex Indices
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
The Bank of England
Neil Wilson 2024 Jan 25, 08:03

Week ahead: Fed, BoE to hold; Apple leads big tech earnings

Forex Indices
Moderna Share Price
Georgy Istigechev 2024 Jan 03, 08:01

Moderna share price jumps as Oppenheimer upgrades stock

Shares

Últimas notícias

Mostrar mais
Noah Lee 2025 Aug 07, 06:20

Bank of England Expected to Cut Rates Amid Inflation Concerns and Slowing Growth

Ava Grace 2025 Aug 07, 05:20

Israel Gaza Conflict: Is a New Offensive on the Horizon?

Sophia Claire 2025 Aug 07, 02:20

Fed Vacancy: Will Trump Seek to Install a Powell Successor?

Liam James 2025 Aug 07, 01:20

Lula Rejects 'Humiliation', Weighs Options Against Trump Tariffs

BoE comments boost investor confidence of interest rate cuts
Tommy Yap 2025 Aug 06, 21:00

Morning Note: BoE Rate Cut Expected; USD Weakens; BOJ Urged Caution

Morning Note Central Banks Forex Monetary Policy
Ghko B 2025 Aug 06, 16:00

Nvidia Stock Is Slipping: what’s happening with Nvidia (NASDAQ: NVDA)?

Stocks
Ava Grace 2025 Aug 06, 15:20

Trump Imposes Tariffs on India Over Russian Energy Imports Amid Ukraine Tensions

Liam James 2025 Aug 06, 14:20

Kashkari Hints at Possible Near-Term Rate Cut Amidst Economic Slowdown

Info

Spread

0.50

Spread (%)

0.6318 %

Alavancagem

1:10

Juro overnight, Compra

-0.0597 %

Juro overnight, Venda

-0.0292 %

Moeda

USD

Horários de Negociação

Mercados fechados

Quinta-feira

13:31 - 19:59

Segunda-feira

13:31-19:59

Terça-feira

13:31-19:59

Quarta-feira

13:31-19:59

Sexta-feira

13:31-19:59

Análise e estatística

Abertura

---

Fechamento anterior

---

Alta/baixa em 52 semanas

--- – ---

Capitalização de mercado

202865934336

Ações em circulação

2497779968

Data dos rendimentos (Próxima)

2021-06-03

Rendim Divid

2025-10-07

Data Ex-Dividendos

2025-09-15

Taxa anual futura de dividendos

3.24

Rendimento anual futuro de dividendos

0.0408

EPS

6.49

Saiba mais sobre este instrumento

MerckCo USA Merck & Company Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and ant

Instrumentos relacionados

Ativo
Venda
Comprar
Alteração (%):
Instrumentos relacionados

latest_education_articles

Mostrar mais
Trustpilot